Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17532-17540
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17532
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17532
Figure 4 Receiver operating characteristic curve for cathepsin L (ng/mL) (A); Kaplan Meier survival curve for low (≤ 5 ng/mL; blue line) and high (> 5 ng/mL; red line) cathepsin L levels in plasma of pancreatic cancer patients (B); Kaplan Meier survival curve for pancreatic cancer patients with stage I and II (blue line) or stage III and IV (red line) disease (C).
- Citation: Singh N, Das P, Gupta S, Sachdev V, Srivasatava S, Datta Gupta S, Pandey RM, Sahni P, Chauhan SS, Saraya A. Plasma cathepsin L: A prognostic marker for pancreatic cancer. World J Gastroenterol 2014; 20(46): 17532-17540
- URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17532.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17532